U.S. Commercialization - Health Technology Insights

Bridge to Life Names David Castiglioni CCO for VitaSmart US Launch

September 29, 2025

Bridge to Life Ltd., a top company in organ preservation and perfusion technology, has named David Castiglioni as its Chief Commercial Officer. In this role,

OS Therapies, EVERSANA Commercialize OST-HER2

June 10, 2025

OS Therapies Inc., a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, has selected EVERSANA, a leading provider of global commercial services to the life

Spectral AI Raises $15Million in Debt for U.S. Commercialization

March 24, 2025

Spectral AI, Inc., a leading developer of the AI-driven DeepView System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential, announced the

Categories

Tag: U.S. Commercialization

Bridge to Life Names David Castiglioni CCO for VitaSmart US Launch

OS Therapies, EVERSANA Commercialize OST-HER2

Spectral AI Raises $15Million in Debt for U.S. Commercialization

Share With

Recent Posts

Health Technology Insights: Latest News And Innovations – Roundup 7 November 2025

Baxter Foundation Grants $2.6Million for STEM Education in Chicago

AI-Driven Athlete Care: Value of Physiotherapy and Counselling in Sports

CMS Teams with Humata Health to Streamline Clinical Approvals

Lumonus Raises A$25 Million in Series B to Scale AI Powered Oncology Workflows Globally

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands